San Diego, CA — Synthetic Genomics, Inc. (SGI), a leader in designing and programming biology for function, today announced J. Craig Venter, Ph.D., has retired from his longtime position as Chairman of the company’s Board of Directors to focus on his work at the J. Craig Venter Institute (JCVI). Dr. Venter will remain a Scientific […]
Ft. Collins, CO (Fort Collins, CO) – KromaTiD, Inc. announced today that it has been awarded a Fast-Track Small Business Innovation Research (SBIR) grant by the National Human Genome Research Institute. The SBIR program enables scientific excellence and technological innovation by incentivizing small businesses to engage in commercial research and development. This award will fund the […]
Wageningen, Netherlands; San Carlos, CA, USA Today NuGEN Technologies, Inc. and Keygene N.V. announced an agreement to settle a declaratory judgment lawsuit brought by NuGEN Technologies concerning KeyGene’s U.S. Patent Nos. 9,702,004, 9,745,627 and 9,896,721. Under the terms of the settlement, the lawsuit and counterclaims have been dismissed. Financial terms and other specifics of the settlement were […]
BEIJING & CAMBRIDGE, Mass.–EdiGene Inc., which develops genome editing technologies into novel therapeutics for a broad range of diseases and into creative solutions to advance drug discovery, today announced the successful completion of approximately $15 Million in a Series pre-B financing. The financing is led by new investor Lilly Asia Ventures (LAV). New investor Huagai […]
Genomic Vision grants European Equity Partner (EEP) a license to its proprietary technology. During the evaluation period, the parties will confirm interest of molecular combing as a genome integrity assay as a quality control tool in biomanufacturing of proteins This strategic collaboration is aimed at building a Bioanalytical Services Company offering specific leading analytical services […]
Oxford – Oxford Genetics, a leader in innovative synthetic biology-based technologies for biologics discovery, development and delivery, has secured a multi-million pound contract with a leading multi-billion dollar global ecommerce provider of reagents and tools to the research and clinical community. As part of the agreement, Oxford Genetics will leverage its high throughput automated genomic engineering […]
Two Leading Centers to Explore Spatial Genomics Synergies with Single-Cell Biology, Next-Generation Sequencing, and Advanced Imaging Technologies Announces Early Access Launch for Five Additional Beta Instruments SEATTLE — NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today announced that the company has added two new Centers of Excellence […]
Powerful, flexible and easy-to-use analysis solution gets the most out of NGS data Oxford, UK. Oxford Gene Technology (OGT), The Molecular Genetics Company, has announced the launch of the eagerly-anticipated update to its SureSeq™ Interpret software, included with purchases of SureSeq NGS panels. Designed to help researchers effortlessly translate cumbersome NGS data into meaningful results, OGT has […]
TUCSON, Ariz. — HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a provider of instruments, reagents, and services for molecular profiling applications and Oncologie, Inc. an innovative biotechnology company with operations in Boston and Shanghai, today announced the completion of a master agreement where the companies have agreed to partner on the development of biomarkers associated with […]
Group sales of EUR 335.6 million with organic growth of 8.6 percent in local currencies Operating result increases by 6.4 percent to EUR 67.3 million; EBIT margin of 20.0 percent Enhancements in sales & distribution and accelerated innovation are confirmed as success factors Hamburg – The Eppendorf Group continued to perform well in the first […]
Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
